Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Preclinical study indicates potential of OGT-918 in treating complicated metabolic disorders

June 3, 1999

Ketone-based hematopoietic agents developed at Toray

June 3, 1999

Licensing opportunity from Cornell Research Foundation: antidiabetic fagopyritols

June 3, 1999

Plant-based Novogen product increases HDL cholesterol

June 3, 1999

Squalene synthase inhibitor BMS-184494 tested in humans; spotlight on squalene synthase inhibitors

June 3, 1999

Orlistat as adjunct to hypocaloric diet reduces CVD risk factors in obesity

June 2, 1999

Small study indicates therapeutic potential of sildenafil in women with sexual arousal disorders

June 1, 1999

New cholesterol-binding agent on the road to launch in Japan

June 1, 1999

GW-0072, a novel PPARgamma receptor ligand with unique biological activities

May 31, 1999

Novel bicyclic compounds useful for lipid disorders, diabetes, obesity, etc.

May 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...